#243 Diabetes Triple Distilled
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
4.8 • 3.1K Ratings
🗓️ 23 November 2020
⏱️ 47 minutes
🧾️ Download transcript
Summary
Listen in as we recap four of our favorite diabetes episodes to bring you the pearls you need to stay up to date on type 2 diabetes management in the clinic. We cover pitfalls of A1c testing, guidelines for A1C targets, when and how to use the newer medications SGLT-2 inhibitors and GLP-1 agonists. We wrap up with a discussion of managing DM2 in patients with kidney disease and in which patients to consider de-intensifying treatment. Feel confident managing diabetes with the latest data in 2020!
Listeners can claim 4 HOURS of Free CE credit for this episode through VCU Health at http://curbsiders.vcuhealth.org/ (CME goes live at 0900 ET on the episode’s release date).
Show Notes | Spotify | Swag! | Top Picks | Mailing List | [email protected] | CME!
Credits
- Written and Produced by: Molly Heublein, MD
- Infographic and Cover Art: Isabel Valdez, PA
- Show Notes: Isabel Valdez, PA; Molly Heublein, MD
- Hosts: Stuart Brigham MD; Matthew Watto MD, FACP; Paul Williams MD, FACP, Molly Heublein, MD
- Editors: Emi Okamoto MD (written materials); Clair Morgan of nodderly.com
Sponsors:
ACP’s I Raise the Rates
Join with other clinicians in working to raise influenza and other adult vaccination rates. Visit acponline.org/ai to access free tools and learn new strategies to support your efforts.
VCU Health CE
The Curbsiders are partnering with VCU Health Continuing Education to offer FREE continuing education credits for physicians and other healthcare professionals. Visit curbsiders.vcuhealth.org and search for this episode to claim credit. See info sheet for further directions. Note: A free VCU Health CloudCME account is required in order to seek credit.
Time Stamps
0:00 Intro,
2:45 Pitfalls of A1c testing,
7:00 Diabetes goals/A1c guidelines; Macrovascular vs Microvascular benefits,
16:20 Choosing between SGLT2 inhibitors vs GLP1 agonists,
19:10 Stuart rants on insulin for symptomatic hyperglycemia,
22:32 Start your patient on an SGLT2i and counsel them about potential adverse events,
30:30 GLP-1 agonists,
36:50 Deintensification; Diabetes Treatment in CKD,
Tags
Diabetes, hypoglycemia, SGLT2 inhibitors, GLP-1 agonist, metformin, CKD, primary care, assistant, doctor, education, family, health, hospitalist, hospital, internal, internist, meded, medical, medicine, nurse, practitioner, professional, physician, resident, student
Transcript
Click on a timestamp to play from that location
| 0:00.0 | This episode of the curbsiders is sponsored by the American College of Physicians. |
| 0:04.6 | I raise the rates immunization initiative. |
| 0:08.7 | National Influenza Vaccination Week is coming December 6th through 12th. |
| 0:12.6 | Visit ACPOnline.org forward slash AI to access free resources to raise adult immunization |
| 0:19.7 | rates and protect your patient's health during flu season. |
| 0:27.2 | The curbsiders podcast is for entertainment, education, and information purposes only. |
| 0:30.0 | On the topic of discussion, it should not be used solely to diagnose, treat, cure, or prevent |
| 0:32.3 | any diseases or conditions. |
| 0:33.3 | For the more the views and statements expressed on the podcast are solely those of those, |
| 0:35.3 | it should not be interpreted to reflect the official policy or position of any entity |
| 0:37.4 | aside from possibly cash-like-more-hospital and affiliate outreach programs. |
| 0:39.8 | If indeed there are any, in fact there are none. |
| 0:41.6 | Pretty much we aren't responsible if you screw up, you should always do your homework |
| 0:43.4 | and let's know if we're wrong. |
| 0:55.4 | Welcome back to the curbsiders, we're going to make this short and sweet, high-stuart. |
| 1:00.2 | We are here doing a very rapid-fire recap of several diabetes episodes that we've done |
| 1:06.6 | over the last few years. |
| 1:08.6 | And we're really going to focus on A1C targets and how our listeners can feel comfortable |
| 1:12.2 | using the newer agents, the GLP1 agonist, the SGLT2 inhibitors. |
| 1:17.4 | Paul, will you tell them in general who are we and what do we do? |
| 1:22.2 | Sure, Matt. |
| 1:23.2 | General, we are the internal medicine podcast, ordinarily we use expert interviews to bring |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Curbsiders Internal Medicine Podcast, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Curbsiders Internal Medicine Podcast and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.